Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

Hall, E D; Andrus, P K; Oostveen, J A; Althaus, J S; VonVoigtlander, P F

Hall, E D; Andrus, P K; Oostveen, J A; Althaus, J S; VonVoigtlander, P F.

Affiliation

Hall ED; CNS Diseases Research, Pharmacia and Upjohn Inc., Kalamazoo, MI 49001, USA.

Brain Res ; 742(1-2): 80-8, 1996 Dec 02.

Article in En | MEDLINE | ID: mdl-9117424

Subject(s)

Brain Ischemia/drug therapy; Corpus Striatum/drug effects; Dopamine Agonists/pharmacology; Nerve Degeneration/drug effects; Substantia Nigra/drug effects; Thiazoles/pharmacology; Animals; Benzothiazoles; Dose-Response Relationship, Drug; Gerbillinae; Male; Methamphetamine/pharmacology; Pramipexole

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Substantia Nigra / Brain Ischemia / Dopamine Agonists / Corpus Striatum / Nerve Degeneration Limits: Animals Language: En Journal: Brain Res Year: 1996 Document type: Article Affiliation country: United States Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links